152 related articles for article (PubMed ID: 30408085)
1. Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.
Seyed Jafari SM; Wiedmer C; Cazzaniga S; Frangež Ž; Shafighi M; Beltraminelli H; Weber B; Simon HU; Hunger RE
PLoS One; 2018; 13(11):e0207019. PubMed ID: 30408085
[TBL] [Abstract][Full Text] [Related]
2. Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.
Mehnert JM; McCarthy MM; Jilaveanu L; Flaherty KT; Aziz S; Camp RL; Rimm DL; Kluger HM
Hum Pathol; 2010 Mar; 41(3):375-84. PubMed ID: 20004943
[TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma.
Lu J; Cheng Y; Zhang G; Tang Y; Dong Z; McElwee KJ; Li G
Mol Med Rep; 2015 Aug; 12(2):2668-76. PubMed ID: 25954957
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.
Maiques O; Macià A; Moreno S; Barceló C; Santacana M; Vea A; Herreros J; Gatius S; Ortega E; Valls J; Chen BJ; Llobet-Navas D; Matias-Guiu X; Cantí C; Marti RM
Br J Dermatol; 2017 May; 176(5):1247-1258. PubMed ID: 27718503
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.
Prins MJ; Verhage RJ; ten Kate FJ; van Hillegersberg R
J Gastrointest Surg; 2012 May; 16(5):956-66. PubMed ID: 22258871
[TBL] [Abstract][Full Text] [Related]
8. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
Bayer-Garner IB; Hough AJ; Smoller BR
Mod Pathol; 1999 Aug; 12(8):770-4. PubMed ID: 10463478
[TBL] [Abstract][Full Text] [Related]
11. Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
Costache MI; Iordache S; Costache CA; Dragos E; Dragos A; Saftoiu A
J Gastrointestin Liver Dis; 2017 Mar; 26(1):51-57. PubMed ID: 28338114
[TBL] [Abstract][Full Text] [Related]
12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
13. Automated quantification of MART1-verified Ki-67 indices: useful diagnostic aid in melanocytic lesions.
Nielsen PS; Spaun E; Riber-Hansen R; Steiniche T
Hum Pathol; 2014 Jun; 45(6):1153-61. PubMed ID: 24704158
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
[No Abstract] [Full Text] [Related]
15. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
17. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
[TBL] [Abstract][Full Text] [Related]
18. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
20. Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
Zlobec I; Koelzer VH; Dawson H; Perren A; Lugli A
J Transl Med; 2013 Apr; 11():104. PubMed ID: 23627766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]